What were Calumet's key financial outcomes for Q2 and H1 2026 as reported in the news?

Calumet, Inc. reported increased sales in Q2 2026 but a wider net loss for H1 2026, driven by ongoing profitability pressures despite revenue growth; while Q2 saw narrowed losses, the larger first-half loss highlights persistent balance sheet risks and cash generation concerns.

What is central to Calumet's current investment narrative according to the news?

Calumet's investment narrative continues to hinge on its shift to renewables and specialty products offsetting legacy operations and leverage, with debt management being a critical factor.

Calumet's Q2 Revenue Growth and Deeper H1 Loss Alter Investment Case

Aug 17, 2026

Calumet Specialty Products Partners reported increased Q2 sales but a wider first-half net loss driven by profitability pressures. Its investment strategy hinges on shifting to renewables and specialty products while managing significant balance sheet risks.

Simply Wall Street

Is Calumet’s Q2 Revenue Growth but Deeper H1 Loss Altering the Investment Case for Calumet (CLMT)?

Simply Wall Street

2026-03-30

Adams Asset Advisors LLC Holds $102.46M Stake in Calumet, Inc.

2026-03-30

Calumet (NASDAQ:CLMT) Given New $60.00 Price Target at HC Wainwright

2026-03-31

H.C. Wainwright Raises Calumet Stock Price Target to $60 from $33

2026-04-02

Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares